,text,i,1,2,3
0,A. Development,A,A,,
1,A.01. Neurogenesis and Gliogenesis ,A.01,A,A.01,
2,A.01.a. Proliferation: Self-renewal and cell cycle,A.01.a,A,A.01,A.01.a
3,A.01.b. Proliferation: Molecular mechanisms,A.01.b,A,A.01,A.01.b
4,A.01.c. Cell lineage,A.01.c,A,A.01,A.01.c
5,A.01.d. Mechanisms of cell fate ,A.01.d,A,A.01,A.01.d
6,A.01.e. Cell migration ,A.01.e,A,A.01,A.01.e
7,A.01.f. Neuronal differentiation ,A.01.f,A,A.01,A.01.f
8,A.01.g. Glial differentiation and interaction with neurons ,A.01.g,A,A.01,A.01.g
9,A.01.h. Nervous system patterning and developmental cell death,A.01.h,A,A.01,A.01.h
10,A.02. Postnatal Neurogenesis,A.02,A,A.02,
11,A.02.a. Postnatal neurogenesis: Temporal and spatial patterns ,A.02.a,A,A.02,A.02.a
12,A.02.b. Postnatal neurogenesis: Molecular mechanisms ,A.02.b,A,A.02,A.02.b
13,A.02.c. Postnatal neurogenesis: Environmental and pharmacological regulation,A.02.c,A,A.02,A.02.c
14,A.03. Stem Cells ,A.03,A,A.03,
15,A.03.a. Induced pluripotent stem cells and models of disease,A.03.a,A,A.03,A.03.a
16,A.03.b. Neural differentiation of pluripotent stem cells,A.03.b,A,A.03,A.03.b
17,A.04. Axon and Dendrite Development ,A.04,A,A.04,
18,A.04.a. Axon growth and guidance: Cytoskeletal dynamics,A.04.a,A,A.04,A.04.a
19,A.04.b. Axon growth and guidance: Adhesion molecules,A.04.b,A,A.04,A.04.b
20,A.04.c. Axon growth and guidance: Intrinsic mechanisms,A.04.c,A,A.04,A.04.c
21,A.04.d. Axon growth and guidance: Extrinsic mechanisms,A.04.d,A,A.04,A.04.d
22,A.04.e. Dendritic growth and branching,A.04.e,A,A.04,A.04.e
23,A.05. Synaptogenesis and Activity-Dependent Development ,A.05,A,A.05,
24,A.05.a. Synapse formation and activity-dependent changes in connectivitiy,A.05.a,A,A.05,A.05.a
25,A.05.b. Activity-dependent changes in connectivity and growth and remodeling of synapses,A.05.b,A,A.05,A.05.b
26,"A.06. Development of Motor, Sensory, and Limbic Systems ",A.06,A,A.06,
27,A.06.a. Motor systems ,A.06.a,A,A.06,A.06.a
28,A.06.b. Sensory systems,A.06.b,A,A.06,A.06.b
29,A.06.c. Limbic system,A.06.c,A,A.06,A.06.c
30,A.07. Transplantation and Regeneration ,A.07,A,A.07,
31,A.07.a. Transplantation,A.07.a,A,A.07,A.07.a
32,A.07.b. Regeneration: PNS ,A.07.b,A,A.07,A.07.b
33,A.07.c. Regeneration: CNS,A.07.c,A,A.07,A.07.c
34,A.08. Evolution of Developmental Mechanisms ,A.08,A,A.08,
35,A.08.a. Evolution of developmental mechanisms,A.08.a,A,A.08,A.08.a
36,A.09. Adolescent Development ,A.09,A,A.09,
37,A.09.a. Animal models,A.09.a,A,A.09,A.09.a
38,A.09.b. Human imaging,A.09.b,A,A.09,A.09.b
39,A.09.c. Mechanisms of vulnerability,A.09.c,A,A.09,A.09.c
40,Back to Top »,,,,
41,,,,,
42,"B. Neural Excitability, Synapses, and Glia: Cellular Mechanisms",B,B,,
43,B.01. Neurotransmitters and Signaling Molecules ,B.01,B,B.01,
44,B.01.a. Amino acids,B.01.a,B,B.01,B.01.a
45,B.01.b. Monoamines,B.01.b,B,B.01,B.01.b
46,B.01.c. Acetylcholine,B.01.c,B,B.01,B.01.c
47,B.01.d. Retrograde messengers,B.01.d,B,B.01,B.01.d
48,"B.01.e. Opiates, Cytokines, and other neuropeptides",B.01.e,B,B.01,B.01.e
49,B.01.f. Neurotrophins,B.01.f,B,B.01,B.01.f
50,B.01.g. Invertebrate neurotransmitters,B.01.g,B,B.01,B.01.g
51,B.02. Ligand-Gated Ion Channels ,B.02,B,B.02,
52,B.02.a. Nicotinic acetylcholine receptors in brain: Physiology and function ,B.02.a,B,B.02,B.02.a
53,B.02.b. Nicotinic acetylcholine receptors: Structure and regulation ,B.02.b,B,B.02,B.02.b
54,B.02.c. NMDA receptors ,B.02.c,B,B.02,B.02.c
55,B.02.d. Non-NMDA receptors ,B.02.d,B,B.02,B.02.d
56,B.02.e. GABA(A) receptors ,B.02.e,B,B.02,B.02.e
57,B.02.f. Glycine receptors & other ligand gated ion channels ,B.02.f,B,B.02,B.02.f
58,B.02.g. TRP channels,B.02.g,B,B.02,B.02.g
59,B.03. G-Protein Coupled Receptors ,B.03,B,B.03,
60,B.03.a. Metabotropic glutamate and GABA B receptors ,B.03.a,B,B.03,B.03.a
61,B.03.b. Other Metabotropic receptors ,B.03.b,B,B.03,B.03.b
62,B.03.c. Peptide receptors,B.03.c,B,B.03,B.03.c
63,B.03.d. Opioid receptors ,B.03.d,B,B.03,B.03.d
64,B.03.e. Purine receptors,B.03.e,B,B.03,B.03.e
65,B.04. Ion Channels ,B.04,B,B.04,
66,B.04.a. Sodium channels ,B.04.a,B,B.04,B.04.a
67,B.04.b. Calcium channels,B.04.b,B,B.04,B.04.b
68,B.04.c. Potassium channels,B.04.c,B,B.04,B.04.c
69,B.04.d. HCN and non-selective cation channels ,B.04.d,B,B.04,B.04.d
70,B.04.e. Other ion channels,B.04.e,B,B.04,B.04.e
71,B.05. Transporters ,B.05,B,B.05,
72,B.05.a. Glutamate,B.05.a,B,B.05,B.05.a
73,B.05.b. Monoamine,B.05.b,B,B.05,B.05.b
74,B.05.c. Other,B.05.c,B,B.05,B.05.c
75,B.06. Neurotransmitter Release ,B.06,B,B.06,
76,"B.06.a. Vesicle docking, fusion, recycling, biogenesis",B.06.a,B,B.06,B.06.a
77,B.06.b. Presynaptic organization and structure ,B.06.b,B,B.06,B.06.b
78,B.07. Synaptic Transmission ,B.07,B,B.07,
79,B.07.a. Postsynaptic organization and structure ,B.07.a,B,B.07,B.07.a
80,B.07.b. Synaptic integration ,B.07.b,B,B.07,B.07.b
81,B.07.c. Electrical synapses and gap junctions ,B.07.c,B,B.07,B.07.c
82,B.07.d. Modulation: Peptides and amines ,B.07.d,B,B.07,B.07.d
83,"B.07.e. Modulation: ACh, amino acids and GABA ",B.07.e,B,B.07,B.07.e
84,B.07.f. Modulation: Mechanisms of action ,B.07.f,B,B.07,B.07.f
85,B.07.g. Modulation: Pharmacology,B.07.g,B,B.07,B.07.g
86,B.08. Synaptic Plasticity ,B.08,B,B.08,
87,B.08.a. Short-term plasticity ,B.08.a,B,B.08,B.08.a
88,B.08.b. LTP: Kinases and intracellular signaling,B.08.b,B,B.08,B.08.b
89,B.08.c. LTP: Pre- and Postsynaptic mechanisms,B.08.c,B,B.08,B.08.c
90,B.08.d. Long-term depression (LTD),B.08.d,B,B.08,B.08.d
91,B.08.e. Spike-timing dependent plasticity,B.08.e,B,B.08,B.08.e
92,B.08.f. Homeostatic plasticity,B.08.f,B,B.08,B.08.f
93,B.08.g. Structural plasticity,B.08.g,B,B.08,B.08.g
94,B.08.h. Transcription and translation in plasticity,B.08.h,B,B.08,B.08.h
95,B.08.i. Other,B.08.i,B,B.08,B.08.i
96,B.09. Network Interactions ,B.09,B,B.09,
97,B.09.a. Signal propagation,B.09.a,B,B.09,B.09.a
98,B.09.b. Oscillations and synchrony: Unit studies,B.09.b,B,B.09,B.09.b
99,B.09.c. Oscillations and synchrony: EEG studies ,B.09.c,B,B.09,B.09.c
100,B.09.d. Oscillations and synchrony: Other,B.09.d,B,B.09,B.09.d
101,B.10. Intrinsic Membrane Properties  ,B.10,B,B.10,
102,B.10.a. Neural oscillators and activity-dependent plasticity of intrinsic membrane properties,B.10.a,B,B.10,B.10.a
103,B.10.b. Modulation of neuronal firing properties ,B.10.b,B,B.10,B.10.b
104,B.10.c. Dendritic excitability and synaptic integration,B.10.c,B,B.10,B.10.c
105,B.11. Glial Mechanisms ,B.11,B,B.11,
106,B.11.a. Astrocytes: Molecular approach,B.11.a,B,B.11,B.11.a
107,B.11.b. Astrocytes: Cell biology,B.11.b,B,B.11,B.11.b
108,B.11.c. Oligodendrocytes ,B.11.c,B,B.11,B.11.c
109,B.11.d. Glia-neuron interactions,B.11.d,B,B.11,B.11.d
110,B.11.e. In vivo approaches,B.11.e,B,B.11,B.11.e
111,Back to Top »,,,,
112,,,,,
113,C. Disorders of the Nervous System,C,C,,
114,C.01. Brain Wellness ,C.01,C,C.01,
115,C.01.a. Brain wellness,C.01.a,C,C.01,C.01.a
116,C.01.b. Metabolism and energetics,C.01.b,C,C.01,C.01.b
117,C.02. Alzheimer's Disease and Other Dementias  ,C.02,C,C.02,
118,C.02.a. Physiological functions and processing of APP and APP metabolites ,C.02.a,C,C.02,C.02.a
119,C.02.b. APP/Abeta: Animal models ,C.02.b,C,C.02,C.02.b
120,C.02.c. APP/Abeta: Cellular models ,C.02.c,C,C.02,C.02.c
121,C.02.d. Tau: Animal models ,C.02.d,C,C.02,C.02.d
122,C.02.e. Tau: Related cellular models ,C.02.e,C,C.02,C.02.e
123,C.02.f. Tau: Biochemistry ,C.02.f,C,C.02,C.02.f
124,C.02.g. APP-Abeta/tau models ,C.02.g,C,C.02,C.02.g
125,C.02.h. In vivo Abeta toxicity ,C.02.h,C,C.02,C.02.h
126,C.02.i. In vitro Abeta toxicity ,C.02.i,C,C.02,C.02.i
127,C.02.j. Abeta biochemistry ,C.02.j,C,C.02,C.02.j
128,C.02.k. Alzheimer's disease: Genetic analyses ,C.02.k,C,C.02,C.02.k
129,C.02.l. Alzheimer’s Disease: Biochemical approaches in animals ,C.02.l,C,C.02,C.02.l
130,C.02.m. Alzheimer's disease: In vivo approaches in humans ,C.02.m,C,C.02,C.02.m
131,C.02.n. Alzheimer's disease: In vitro therapeutics ,C.02.n,C,C.02,C.02.n
132,C.02.o. Alzheimer's disease: Neuroinflammation and immune actions ,C.02.o,C,C.02,C.02.o
133,"C.02.p. Beta and gamma secretase, BACE and presenilin ",C.02.p,C,C.02,C.02.p
134,C.02.q. Abeta metabolism ,C.02.q,C,C.02,C.02.q
135,C.02.r. Anti-Abeta treatments ,C.02.r,C,C.02,C.02.r
136,C.02.s. ApoE and cholesterol ,C.02.s,C,C.02,C.02.s
137,C.02.t. Tauopathies ,C.02.t,C,C.02,C.02.t
138,C.02.u. Abnormal pathological proteins excluding tau and Abeta ,C.02.u,C,C.02,C.02.u
139,C.02.v. Cognitive function ,C.02.v,C,C.02,C.02.v
140,C.02.w. Neuropharmacology and neurotransmitters ,C.02.w,C,C.02,C.02.w
141,C.02.x. Synaptic biology related to Alzheimer’s disease ,C.02.x,C,C.02,C.02.x
142,C.02.y. Genetics and functional genomics ,C.02.y,C,C.02,C.02.y
143,C.02.z. Imaging and biomarkers,C.02.z,C,C.02,C.02.z
144,C.03. Parkinson’s Disease  ,C.03,C,C.03,
145,C.03.a. Human studies,C.03.a,C,C.03,C.03.a
146,C.03.b. Degeneration models,C.03.b,C,C.03,C.03.b
147,C.03.c. Transgenic and related mouse models,C.03.c,C,C.03,C.03.c
148,C.03.d. Rat and mouse toxin and behavior models,C.03.d,C,C.03,C.03.d
149,C.03.e. Mechanisms and degeneration treatment ,C.03.e,C,C.03,C.03.e
150,C.03.f. Clinical therapies,C.03.f,C,C.03,C.03.f
151,C.03.g. Animal therapies ,C.03.g,C,C.03,C.03.g
152,C.03.h. Cellular mechanisms,C.03.h,C,C.03,C.03.h
153,C.03.i. Circuit mechanisms,C.03.i,C,C.03,C.03.i
154,C.03.j. Dopamine and non-dopamine pathways,C.03.j,C,C.03,C.03.j
155,C.03.k. Mechanisms of cell death and dysfunction,C.03.k,C,C.03,C.03.k
156,C.03.l. Neuroprotective mechanisms,C.03.l,C,C.03,C.03.l
157,C.04. Neurodegenerative Disorders and Movement Disorders  ,C.04,C,C.04,
158,C.04.a. Huntington's disease: Mechanisms and more,C.04.a,C,C.04,C.04.a
159,C.04.b. Huntington's disease: Animal models,C.04.b,C,C.04,C.04.b
160,C.04.c. Repeat expansion diseases: Non-Huntington’s disease,C.04.c,C,C.04,C.04.c
161,C.04.d. Ataxias,C.04.d,C,C.04,C.04.d
162,C.04.e. Motor neuron disease: Cellular mechanisms,C.04.e,C,C.04,C.04.e
163,C.04.f. Motor neuron disease: In vitro studies,C.04.f,C,C.04,C.04.f
164,C.04.g. Motor neuron disease: Animal models,C.04.g,C,C.04,C.04.g
165,C.04.h. Motor neuron disease: Therapeutics ,C.04.h,C,C.04,C.04.h
166,C.04.i. Dystonia,C.04.i,C,C.04,C.04.i
167,C.04.j. Other neurodegenerative disorders,C.04.j,C,C.04,C.04.j
168,C.04.k. Neuromuscular diseases,C.04.k,C,C.04,C.04.k
169,C.05. Aging  ,C.05,C,C.05,
170,C.05.a. Molecular mechanisms and oxidative stress,C.05.a,C,C.05,C.05.a
171,C.05.b. Physiological and molecular correlates,C.05.b,C,C.05,C.05.b
172,C.06. Developmental Disorders  ,C.06,C,C.06,
173,C.06.a. Autism: Behavioral analysis,C.06.a,C,C.06,C.06.a
174,C.06.b. Autism: Genetic models,C.06.b,C,C.06,C.06.b
175,C.06.c. Autism: Synaptic and cellular mechanisms,C.06.c,C,C.06,C.06.c
176,C.06.d. Autism: Environment and pathology,C.06.d,C,C.06,C.06.d
177,C.06.e. Autism: Physiology and systems,C.06.e,C,C.06,C.06.e
178,C.06.f. Rett syndrome,C.06.f,C,C.06,C.06.f
179,C.06.g. Fragile X ,C.06.g,C,C.06,C.06.g
180,C.06.h. Down syndrome ,C.06.h,C,C.06,C.06.h
181,C.06.i. Angelman and other developmental disorders,C.06.i,C,C.06,C.06.i
182,"C.06.j. ADHD, SLI, dyslexia and other specific disorders of neurobehavior",C.06.j,C,C.06,C.06.j
183,C.06.k. Animal models and mechanisms,C.06.k,C,C.06,C.06.k
184,C.07. Epilepsy ,C.07,C,C.07,
185,C.07.a. Genetics,C.07.a,C,C.07,C.07.a
186,C.07.b. Channels,C.07.b,C,C.07,C.07.b
187,C.07.c. Synaptic mechanisms,C.07.c,C,C.07,C.07.c
188,C.07.d. Networks,C.07.d,C,C.07,C.07.d
189,C.07.e. Post-seizure modifications,C.07.e,C,C.07,C.07.e
190,C.07.f. In vivo and behavior,C.07.f,C,C.07,C.07.f
191,C.07.g. Animal models,C.07.g,C,C.07,C.07.g
192,C.07.h. Anticonvulsant and antipileptic therapies ,C.07.h,C,C.07,C.07.h
193,C.07.i. Human Studies,C.07.i,C,C.07,C.07.i
194,C.08. Ischemia ,C.08,C,C.08,
195,C.08.a. Cellular mechanisms ,C.08.a,C,C.08,C.08.a
196,C.08.b. Molecular mechanisms,C.08.b,C,C.08,C.08.b
197,C.08.c. Ischemia: Perinatal,C.08.c,C,C.08,C.08.c
198,C.08.d. Ischemia: Recovery ,C.08.d,C,C.08,C.08.d
199,C.08.e. Ischemia and Hemorrahage: Animal Models,C.08.e,C,C.08,C.08.e
200,C.08.f. Inflammation,C.08.f,C,C.08,C.08.f
201,C.08.g. Neuroprotection: In vivo studies,C.08.g,C,C.08,C.08.g
202,C.08.h. Neuroprotection:  In vitro studies,C.08.h,C,C.08,C.08.h
203,C.08.i. Cell based therapies,C.08.i,C,C.08,C.08.i
204,C.08.j. Human and translational studies,C.08.j,C,C.08,C.08.j
205,C.09. Demyelinating Disorders ,C.09,C,C.09,
206,C.09.a. Molecular and cellular mechanisms ,C.09.a,C,C.09,C.09.a
207,C.09.b. Therapeutics,C.09.b,C,C.09,C.09.b
208,C.09.c. Human and animal studies,C.09.c,C,C.09,C.09.c
209,C.10. Trauma ,C.10,C,C.10,
210,C.10.a. Brain: Cellular and molecular mechanisms ,C.10.a,C,C.10,C.10.a
211,C.10.b. Brain: Animal models,C.10.b,C,C.10,C.10.b
212,C.10.c. Brain: Human studies,C.10.c,C,C.10,C.10.c
213,C.10.d. Brain: Therapeutic strategies,C.10.d,C,C.10,C.10.d
214,C.10.e. Spinal cord: Cellular and molecular mechanisms,C.10.e,C,C.10,C.10.e
215,C.10.f. Spinal cord: Animal models and human studies ,C.10.f,C,C.10,C.10.f
216,C.10.g. Spinal cord: Therapeutic strategies: In vivo studies with pharmacological approach,C.10.g,C,C.10,C.10.g
217,C.10.h. Spinal cord: Therapeutic strategies: In vitro studies with gene targeting,C.10.h,C,C.10,C.10.h
218,"C.10.i. Peripheral nerve trauma, crush and toxic injury ",C.10.i,C,C.10,C.10.i
219,C.10.j. Spinal cord: Therapeutic strategies: In vitro studies,C.10.j,C,C.10,C.10.j
220,"C.11. Neurotoxicity, Inflammation, and Neuroprotection ",C.11,C,C.11,
221,C.11.a. Cell death mechanisms: Apoptosis and mitochondria,C.11.a,C,C.11,C.11.a
222,C.11.b. Cell death mechanisms: Excitotoxicity and calcium,C.11.b,C,C.11,C.11.b
223,C.11.c. Cell death mechanisms: Oxidative stress,C.11.c,C,C.11,C.11.c
224,C.11.d. Neuroprotective mechanisms,C.11.d,C,C.11,C.11.d
225,C.11.e. Neurotoxicity and neurodegeneration,C.11.e,C,C.11,C.11.e
226,C.11.f. Neuroinflammation: Cellular and molecular mechanisms,C.11.f,C,C.11,C.11.f
227,C.11.g. Neuroinflammation: Neurodegeneration,C.11.g,C,C.11,C.11.g
228,C.11.h. Neuroinflammation: Animal models,C.11.h,C,C.11,C.11.h
229,C.11.i. Neuroinflammation: HIV and infections,C.11.i,C,C.11,C.11.i
230,C.12. Neuro-Oncology  ,C.12,C,C.12,
231,C.12.a. Neuro-oncology,C.12.a,C,C.12,C.12.a
232,C.13. Sensory Disorders ,C.13,C,C.13,
233,C.13.a. Visual and auditory ,C.13.a,C,C.13,C.13.a
234,C.13.b. Somatosensory and pain,C.13.b,C,C.13,C.13.b
235,C.14. Gene Therapy  ,C.14,C,C.14,
236,C.14.a. Gene therapy,C.14.a,C,C.14,C.14.a
237,C.15. Schizophrenia and Bi-polar Disorder ,C.15,C,C.15,
238,C.15.a. Neuropathology ,C.15.a,C,C.15,C.15.a
239,C.15.b. Genetics and genomics,C.15.b,C,C.15,C.15.b
240,C.15.c. Human epidemiology and genetics,C.15.c,C,C.15,C.15.c
241,C.15.d. Human behavior and clinical studies,C.15.d,C,C.15,C.15.d
242,C.15.e. Animal models: Non-genetic,C.15.e,C,C.15,C.15.e
243,C.15.f. Mutant animal models ,C.15.f,C,C.15,C.15.f
244,C.15.g. Biochemical studies,C.15.g,C,C.15,C.15.g
245,C.15.h. Experimental therapeutics,C.15.h,C,C.15,C.15.h
246,"C.16. Cognitive, Emotional, and Behavioral State Disorders ",C.16,C,C.16,
247,C.16.a. Mood disorders: Human postmortem studies ,C.16.a,C,C.16,C.16.a
248,C.16.b. Mood disorders: Human biomarkers and treatment studies ,C.16.b,C,C.16,C.16.b
249,C.16.c. Mood disorders: Vertebrate animal models ,C.16.c,C,C.16,C.16.c
250,C.16.d. Mood disorders: Non-mammalian model systems ,C.16.d,C,C.16,C.16.d
251,C.16.e. Mood disorders: Antidepressants ,C.16.e,C,C.16,C.16.e
252,C.16.f. Mood disorders: Mutant animal models ,C.16.f,C,C.16,C.16.f
253,C.16.g. Mood disorders: Preclinical studies and behavioral models ,C.16.g,C,C.16,C.16.g
254,C.16.h. Anxiety disorders: Human biomarkers and treatment studies ,C.16.h,C,C.16,C.16.h
255,C.16.i. Anxiety disorders: Therapeutic approaches ,C.16.i,C,C.16,C.16.i
256,C.16.j. Anxiety approaches: Animal models,C.16.j,C,C.16,C.16.j
257,C.17. Drugs of Abuse and Addiction ,C.17,C,C.17,
258,C.17.a. Alcohol: Intake and preference,C.17.a,C,C.17,C.17.a
259,"C.17.b. Alcohol, Nicotine and Opioids: Tolerance, dependence, and withdrawal ",C.17.b,C,C.17,C.17.b
260,C.17.c. Alcohol: Behavioral effects ,C.17.c,C,C.17,C.17.c
261,C.17.d. Alcohol: Neural mechanisms ,C.17.d,C,C.17,C.17.d
262,C.17.e. Nicotine: Neural mechanisms of addiction ,C.17.e,C,C.17,C.17.e
263,"C.17.f. Nicotine: Reinforcement, seeking and reinstatement ",C.17.f,C,C.17,C.17.f
264,"C.17.g. Alcohol, Nicotine and Cannabinoids: Developmental effects",C.17.g,C,C.17,C.17.g
265,C.17.h. Cocaine: Behavioral studies ,C.17.h,C,C.17,C.17.h
266,C.17.i. Cocaine: Cellular and synaptic studies ,C.17.i,C,C.17,C.17.i
267,"C.17.j. Cocaine reinforcement, seeking, and reinstatement ",C.17.j,C,C.17,C.17.j
268,C.17.k. Amphetamine and related drugs: Neural mechanisms of addiction ,C.17.k,C,C.17,C.17.k
269,"C.17.l. Amphetamine and related drugs: Reinforcement, seeking, and reinstatement ",C.17.l,C,C.17,C.17.l
270,"C.17.m. Cocaine, amphetamine, and related drugs: Toxicity and Developmental Effects",C.17.m,C,C.17,C.17.m
271,C.17.n. Opioids: Neural mechanisms of addiction ,C.17.n,C,C.17,C.17.n
272,"C.17.o. Opioid reinforcement, seeking, and reinstatement",C.17.o,C,C.17,C.17.o
273,C.17.p. Cannabinoids: Neural mechanisms and addiction,C.17.p,C,C.17,C.17.p
274,C.17.q. Addiction: Genetics,C.17.q,C,C.17,C.17.q
275,C.17.r. Addiction treatment: Translational and clinical studies ,C.17.r,C,C.17,C.17.r
276,"C.17.s. Learning, memory, dependence, and addiction",C.17.s,C,C.17,C.17.s
277,"C.17.t. Neural plasticity, dependence, and addiction",C.17.t,C,C.17,C.17.t
278,C.17.u. Addiction: Behavioral pharmacology,C.17.u,C,C.17,C.17.u
279,C.18. Behavioral Pharmacology ,C.18,C,C.18,
280,C.18.a. Neuropeptides and behavior ,C.18.a,C,C.18,C.18.a
281,C.18.b. Monoamines and behavior: Serotonin and histamine,C.18.b,C,C.18,C.18.b
282,C.18.c. Monoamines and behavior: Dopamine and norepinephrine,C.18.c,C,C.18,C.18.c
283,C.19. Drug Discovery and Development ,C.19,C,C.19,
284,C.19.a. Affective disorders and schizophrenia,C.19.a,C,C.19,C.19.a
285,"C.19.b. Neurodegenerative diseases (AD, PD, MS, stroke)",C.19.b,C,C.19,C.19.b
286,"C.19.c. Pain, headache and migraine",C.19.c,C,C.19,C.19.c
287,C.19.d. Drug delivery ,C.19.d,C,C.19,C.19.d
288,C.20.Perinatal Brain Injury ,C.20,C,C.20,C.20.Perinata
289,C.20.a. Acute therapy,C.20.a,C,C.20,C.20.a
290,C.21.Stroke Recovery ,C.21,C,C.21,C.21.Strok
291,C.21.a. Stroke recovery: Pharmacological approaches to therapy,C.21.a,C,C.21,C.21.a
292,C.21.b. Stroke recovery: Non-pharmacological approaches to therapy,C.21.b,C,C.21,C.21.b
293,C.21.c. Stroke imaging and diagnostic studies,C.21.c,C,C.21,C.21.c
294,Back to Top »,,,,
295,,,,,
296,D. Sensory and Motor Systems,D,D,,
297,D.01. Chemical Senses ,D.01,D,D.01,
298,D.01.a. Olfactory receptor cells and transduction,D.01.a,D,D.01,D.01.a
299,D.01.b. Olfactory coding: Second order regions (olfactory bulb and antennal lobe) ,D.01.b,D,D.01,D.01.b
300,D.01.c. Olfactory coding: Higher-order circuits,D.01.c,D,D.01,D.01.c
301,"D.01.d. Olfaction: Behavior, perception, and its relation to neurophysiology",D.01.d,D,D.01,D.01.d
302,D.01.e. Taste,D.01.e,D,D.01,D.01.e
303,D.02. Auditory System,D.02,D,D.02,
304,D.02.a. Mechanoreceptors and cochlea,D.02.a,D,D.02,D.02.a
305,D.02.b. Auditory processing: Sound localization and binaural interactions ,D.02.b,D,D.02,D.02.b
306,"D.02.c. Auditory processing: Temporal, frequency, and spectral processing ",D.02.c,D,D.02,D.02.c
307,D.02.d. Auditory processing: Vocalizations and natural sounds,D.02.d,D,D.02,D.02.d
308,"D.02.e. Auditory processing: Circuits, synapses, neurotransmitters ",D.02.e,D,D.02,D.02.e
309,"D.02.f. Auditory processing: Adaptation, learning, memory",D.02.f,D,D.02,D.02.f
310,"D.02.g. Auditory processing: Neural coding, experiment, and theory ",D.02.g,D,D.02,D.02.g
311,"D.02.h. Auditory processing: Perception, cognition, and action",D.02.h,D,D.02,D.02.h
312,D.03. Multisensory Systems  ,D.03,D,D.03,
313,D.03.a. Cross-modal processing: Spatial factors ,D.03.a,D,D.03,D.03.a
314,D.03.b. Cross-modal processing: Temporal factors ,D.03.b,D,D.03,D.03.b
315,D.03.c. Cross-modal processing: Neural circuitry and development,D.03.c,D,D.03,D.03.c
316,D.03.d. Cross-modal processing: In humans,D.03.d,D,D.03,D.03.d
317,D.04. Vision ,D.04,D,D.04,
318,D.04.a. Retina: Photoreceptors ,D.04.a,D,D.04,D.04.a
319,D.04.b. Retinal circuitry ,D.04.b,D,D.04,D.04.b
320,D.04.c. Subcortical visual pathways ,D.04.c,D,D.04,D.04.c
321,D.04.d. Striate cortex: Circuitry and organization ,D.04.d,D,D.04,D.04.d
322,D.04.e. Striate cortex: Response properties ,D.04.e,D,D.04,D.04.e
323,D.04.f. Striate cortex: Plasticity ,D.04.f,D,D.04,D.04.f
324,D.04.g. Extrastriate cortex ,D.04.g,D,D.04,D.04.g
325,"D.04.h. Processing of contrast, form, and color ",D.04.h,D,D.04,D.04.h
326,D.04.i. Visual motion ,D.04.i,D,D.04,D.04.i
327,D.04.j. Representation of objects ,D.04.j,D,D.04,D.04.j
328,D.04.k. Representation of faces and bodies ,D.04.k,D,D.04,D.04.k
329,"D.04.l. Visual learning, memory, and categorization ",D.04.l,D,D.04,D.04.l
330,"D.04.m. Binocular vision, depth, and stereo ",D.04.m,D,D.04,D.04.m
331,D.04.n. Spatial and feature-based attention ,D.04.n,D,D.04,D.04.n
332,D.04.o. Visual cognition: Decision making,D.04.o,D,D.04,D.04.o
333,D.05. Visual Sensory-Motor Processing  ,D.05,D,D.05,
334,D.05.a. Eye movements and perception ,D.05.a,D,D.05,D.05.a
335,D.05.b. Sensorimotor transformation: Behavior and whole animal,D.05.b,D,D.05,D.05.b
336,D.05.c. Sensorimotor transformation: Higher order functional organization,D.05.c,D,D.05,D.05.c
337,D.05.d. Sensorimotor transformation: Neurophysiology,D.05.d,D,D.05,D.05.d
338,D.05.e. Spatial memory and eye-hand coordination ,D.05.e,D,D.05,D.05.e
339,D.05.f. Visually guided reaching ,D.05.f,D,D.05,D.05.f
340,D.06. Eye Movements  ,D.06,D,D.06,
341,D.06.a. Central mechanisms,D.06.a,D,D.06,D.06.a
342,D.06.b. Eye movements: Saccades,D.06.b,D,D.06,D.06.b
343,D.06.c. Eye movements: Perception and neural mechanisms,D.06.c,D,D.06,D.06.c
344,D.07. Vestibular System,D.07,D,D.07,
345,"D.07.a. Hair cells, end organs, and nerve ",D.07.a,D,D.07,D.07.a
346,D.07.b. Central physiology and anatomy,D.07.b,D,D.07,D.07.b
347,"D.07.c. Perception, posture, and spatial orientation",D.07.c,D,D.07,D.07.c
348,D.08. Pain ,D.08,D,D.08,
349,D.08.a. Pain transduction: TRP channels ,D.08.a,D,D.08,D.08.a
350,D.08.b. Nociceptors: Molecular and pharmacological studies ,D.08.b,D,D.08,D.08.b
351,D.08.c. Nociceptors: Anatomical and physiological studies ,D.08.c,D,D.08,D.08.c
352,D.08.d. Spinal cord processing: Anatomy and physiology ,D.08.d,D,D.08,D.08.d
353,D.08.e. Spinal cord processing: Pharmacology ,D.08.e,D,D.08,D.08.e
354,D.08.f. Trigeminal processing ,D.08.f,D,D.08,D.08.f
355,D.08.g. Thalamic and cortical processing ,D.08.g,D,D.08,D.08.g
356,D.08.h. Descending modulation ,D.08.h,D,D.08,D.08.h
357,D.08.i. Treatments for persistent pain ,D.08.i,D,D.08,D.08.i
358,D.08.j. Pain models: Pharmacology ,D.08.j,D,D.08,D.08.j
359,D.08.k. Pain models: Behavior ,D.08.k,D,D.08,D.08.k
360,D.08.l. Pain models: Physiology ,D.08.l,D,D.08,D.08.l
361,D.08.m. Inflammatory pain ,D.08.m,D,D.08,D.08.m
362,D.08.n. Mechanisms of neuropathic pain ,D.08.n,D,D.08,D.08.n
363,D.08.o. Visceral pain ,D.08.o,D,D.08,D.08.o
364,D.08.p. Musculoskeletal pain ,D.08.p,D,D.08,D.08.p
365,D.08.q. Pain imaging and perception ,D.08.q,D,D.08,D.08.q
366,D.08.r. Opioid receptor pharmacology and signaling mechanisms ,D.08.r,D,D.08,D.08.r
367,D.08.s. Other analgesics,D.08.s,D,D.08,D.08.s
368,D.09. Tactile/Somatosensory Systems,D.09,D,D.09,
369,D.09.a. Receptors and cellular and molecular mechanisms of transduction ,D.09.a,D,D.09,D.09.a
370,D.09.b. Plasticity and reorganization,D.09.b,D,D.09,D.09.b
371,D.09.c. Local cortical circuits ,D.09.c,D,D.09,D.09.c
372,D.09.d. Functional organization,D.09.d,D,D.09,D.09.d
373,D.09.e. Thalamocortical processes,D.09.e,D,D.09,D.09.e
374,D.09.f. Stimulus feature receptive fields and response properties ,D.09.f,D,D.09,D.09.f
375,D.09.g. Stimulus feature neural coding,D.09.g,D,D.09,D.09.g
376,D.09.h. Functional studies,D.09.h,D,D.09,D.09.h
377,D.10. Spinal Cord Injury and Plasticity ,D.10,D,D.10,
378,D.10.a. Spinal cord injury: Posture and locomotion ,D.10.a,D,D.10,D.10.a
379,D.10.b. Spinal cord injury: Recovery ,D.10.b,D,D.10,D.10.b
380,"D.10.c. Spinal cord injury: Training, rehabilitation, and repair",D.10.c,D,D.10,D.10.c
381,D.10.d. Plasticity: Neurophysiology,D.10.d,D,D.10,D.10.d
382,D.10.e. Plasticity: Neurotransmitters and molecular biology,D.10.e,D,D.10,D.10.e
383,D.11. Vertebrate and Invertebrate Rhythmic Motor Pattern Generation  ,D.11,D,D.11,
384,D.11.a. Cellular properties: Interneurons and motor neurons,D.11.a,D,D.11,D.11.a
385,D.11.b. Connectivity,D.11.b,D,D.11,D.11.b
386,D.11.c. Neuromodulation ,D.11.c,D,D.11,D.11.c
387,D.11.d. Afferent and descending control,D.11.d,D,D.11,D.11.d
388,D.11.e. Models,D.11.e,D,D.11,D.11.e
389,D.12. Kinematics and EMG ,D.12,D,D.12,
390,D.12.a. Reflexes and reflex modulation,D.12.a,D,D.12,D.12.a
391,D.13. Motor Neurons and Muscle  ,D.13,D,D.13,
392,"D.13.a. Motor neurons: Activity; sensory and central control; exercise, injury and disease ",D.13.a,D,D.13,D.13.a
393,"D.13.b. Motor neurons: Development, identification, intrinsic properties, modulation",D.13.b,D,D.13,D.13.b
394,"D.13.c. Motor unit recordings, kinematics, and EMG ",D.13.c,D,D.13,D.13.c
395,D.13.d. Motorneuron-muscle interface,D.13.d,D,D.13,D.13.d
396,D.13.e. Muscle physiology and biochemistry,D.13.e,D,D.13,D.13.e
397,D.14. Cerebellum: Central Physiology ,D.14,D,D.14,
398,D.14.a. Cerebellum:  Anatomy and in vitro models,D.14.a,D,D.14,D.14.a
399,D.14.b. Cerebellum: Cortex and nuclei,D.14.b,D,D.14,D.14.b
400,D.14.c. Cerebellum: Plasticity and climbing fibers ,D.14.c,D,D.14,D.14.c
401,D.14.d. Cerebellum: Human studies,D.14.d,D,D.14,D.14.d
402,D.15. Basal Ganglia  ,D.15,D,D.15,
403,D.15.a. Transmitters and neuromodulation,D.15.a,D,D.15,D.15.a
404,D.15.b. Cellular physiology ,D.15.b,D,D.15,D.15.b
405,D.15.c. Small networks and plasticity,D.15.c,D,D.15,D.15.c
406,D.15.d. Systems physiology,D.15.d,D,D.15,D.15.d
407,D.15.e. Systems behavior,D.15.e,D,D.15,D.15.e
408,D.16. Posture and Gait ,D.16,D,D.16,
409,"D.16.a. Posture and gait: Kinematics, muscle activity, exercise and fatique, biomechanics",D.16.a,D,D.16,D.16.a
410,D.16.b. Posture and gait: Afferent control,D.16.b,D,D.16,D.16.b
411,"D.16.c. Posture and gait: Higher order control, multi-task integration, theory",D.16.c,D,D.16,D.16.c
412,"D.16.d. Posture and gait: Aging, injury, and disease",D.16.d,D,D.16,D.16.d
413,D.17. Voluntary Movements ,D.17,D,D.17,
414,D.17.a. Finger and grasp control: Normal human behavior,D.17.a,D,D.17,D.17.a
415,"D.17.b. Finger and grasp control: Age, pathology, and physiology",D.17.b,D,D.17,D.17.b
416,D.17.c. Reaching control: Action and sensation ,D.17.c,D,D.17,D.17.c
417,D.17.d. Reaching control: Movement selection and strategy ,D.17.d,D,D.17,D.17.d
418,D.17.e. Reaching control: Motor learning ,D.17.e,D,D.17,D.17.e
419,D.17.f. Interlimb and bimanual control,D.17.f,D,D.17,D.17.f
420,"D.17.g. Stroke, damage, or disease: Mechanisms of abnormal movement ",D.17.g,D,D.17,D.17.g
421,"D.17.h. Stroke, damage, or disease: Assessment and treatment ",D.17.h,D,D.17,D.17.h
422,D.17.i. Cortical planning and execution: Behavior,D.17.i,D,D.17,D.17.i
423,D.17.j. Cortical planning and execution: Neurophysiology,D.17.j,D,D.17,D.17.j
424,D.17.k. Cortical planning and execution: Neuroimaging,D.17.k,D,D.17,D.17.k
425,D.17.l. Oral motor and speech,D.17.l,D,D.17,D.17.l
426,D.17.m. Plasticity,D.17.m,D,D.17,D.17.m
427,D.18. Brain-Machine Interface ,D.18,D,D.18,
428,D.18.a. Neurophysiology: Non-invasive mechanisms ,D.18.a,D,D.18,D.18.a
429,D.18.b. Neurophysiology: Implanted electrodes and other direct interactions with neurons ,D.18.b,D,D.18,D.18.b
430,"D.18.c. Neuroprosthetics: Control of real and artificial arm, hand, other grasping devices ",D.18.c,D,D.18,D.18.c
431,"D.18.d. Neuroprosthetics: Other motor sensory interfaces (e.g., artificial vision)",D.18.d,D,D.18,D.18.d
432,D.19. Comparative Anatomy and Evolution  ,D.19,D,D.19,
433,D.19.a. Comparative anatomy and Evolution,D.19.a,D,D.19,D.19.a
434,D.20. Respiratory Regulation ,D.20,D,D.20,
435,D.20.a. Respiratory regulation: Central respiratory chemoreception ,D.20.a,D,D.20,D.20.a
436,D.20.b. Respiratory regulation: Respiratory rhythm and pattern generation ,D.20.b,D,D.20,D.20.b
437,D.20.c. Respiratory regulation: Hypoxia and obstructive sleep apnea,D.20.c,D,D.20,D.20.c
438,Back to Top »,,,,
439,,,,,
440,"E. Integrative Systems: Neuroendocrinology, Neuroimmunology and Homeostatic Challenge",E,E,,
441,E.01. Neuroendocrine Processes ,E.01,E,E.01,
442,E.01.a. HPG axis: GnRH cells and gonadotrophins,E.01.a,E,E.01,E.01.a
443,E.01.b. HPG axis: Neural control ,E.01.b,E,E.01,E.01.b
444,E.01.c. Neuroendocrine anatomy and physiology,E.01.c,E,E.01,E.01.c
445,E.01.d. Neurosteroids ,E.01.d,E,E.01,E.01.d
446,E.01.e. Steroids and plasticity ,E.01.e,E,E.01,E.01.e
447,E.01.f. Sexual differentiation,E.01.f,E,E.01,E.01.f
448,E.02. Neuroimmunology  ,E.02,E,E.02,
449,E.02.a. Regulating systems,E.02.a,E,E.02,E.02.a
450,E.02.b. Behavioral effects,E.02.b,E,E.02,E.02.b
451,E.03. Behavioral Neuroendocrinology  ,E.03,E,E.03,
452,E.03.a. Sexual behavior,E.03.a,E,E.03,E.03.a
453,E.03.b. Parental behavior ,E.03.b,E,E.03,E.03.b
454,E.03.c. Social behavior,E.03.c,E,E.03,E.03.c
455,E.03.d. Defensive behavior and aggression ,E.03.d,E,E.03,E.03.d
456,E.03.e. Hormones and cognition,E.03.e,E,E.03,E.03.e
457,E.04. Autonomic Regulation ,E.04,E,E.04,
458,E.04.a. Cardiovascular regulation ,E.04.a,E,E.04,E.04.a
459,E.04.b. Thermoregulation ,E.04.b,E,E.04,E.04.b
460,"E.04.c. Gastrointestinal, renal/urinary, and reproductive regulation",E.04.c,E,E.04,E.04.c
461,E.05. Stress and the Brain ,E.05,E,E.05,
462,E.05.a. Stress and neuroimmunology ,E.05.a,E,E.05,E.05.a
463,E.05.b. Cellular actions of stress ,E.05.b,E,E.05,E.05.b
464,"E.05.c. Early-life Stress: Neural, neurochemical, and physiologic effects ",E.05.c,E,E.05,E.05.c
465,E.05.d. Early-life Stress: Molecular mechanisms and cellular effects ,E.05.d,E,E.05,E.05.d
466,"E.05.e. Early-life Stress: Effects on anxiety, social function, and depression ",E.05.e,E,E.05,E.05.e
467,E.05.f. Early-life Stress: Adolescence ,E.05.f,E,E.05,E.05.f
468,"E.05.g. Stress-modulated pathways: Cortex, hippocampus, and striatum ",E.05.g,E,E.05,E.05.g
469,"E.05.h. Stress-modulated pathways: Hypothalamus, amygdala, and bed nucleus ",E.05.h,E,E.05,E.05.h
470,E.05.i. Stress-modulated pathways: Brainstem and other ,E.05.i,E,E.05,E.05.i
471,E.05.j. Stress and cognition,E.05.j,E,E.05,E.05.j
472,E.06. Thirst and Water Balance ,E.06,E,E.06,
473,E.06.a. Thirst and water balance,E.06.a,E,E.06,E.06.a
474,E.07. Food Intake and Energy Balance  ,E.07,E,E.07,
475,E.07.a. Integration of peripheral signals: Regulators ,E.07.a,E,E.07,E.07.a
476,E.07.b. Integration of peripheral signals: Systems,E.07.b,E,E.07,E.07.b
477,E.07.c. Central pathways: Anatomy and development,E.07.c,E,E.07,E.07.c
478,E.07.d. Neuropeptide regulators ,E.07.d,E,E.07,E.07.d
479,"E.07.e.  Monoamines, amino acids, and other regulators",E.07.e,E,E.07,E.07.e
480,E.08. Biological Rhythms and Sleep  ,E.08,E,E.08,
481,E.08.a. Entrainment and phase shifts,E.08.a,E,E.08,E.08.a
482,E.08.b. Molecular biology and physiology of clocks,E.08.b,E,E.08,E.08.b
483,"E.08.c. Sleep: Molecular, cellular, and pharmacology",E.08.c,E,E.08,E.08.c
484,E.08.d. Sleep: Regulators,E.08.d,E,E.08,E.08.d
485,E.08.e. Sleep: Systems,E.08.e,E,E.08,E.08.e
486,E.08.f. Sleep: Behavior,E.08.f,E,E.08,E.08.f
487,"E.08.g. SCN anatomy, physiology, neurochemistry",E.08.g,E,E.08,E.08.g
488,"E.09. Brain Blood Flow, Metabolism, and Homeostasis ",E.09,E,E.09,
489,E.09.a. Energy metabolism,E.09.a,E,E.09,E.09.a
490,E.09.b. Blood flow ,E.09.b,E,E.09,E.09.b
491,E.09.c. Blood brain barrier,E.09.c,E,E.09,E.09.c
492,E.09.d. Functional imaging,E.09.d,E,E.09,E.09.d
493,Back to Top »,,,,
494,,,,,
495,F. Cognition and Behavior,F,F,,
496,F.01. Human Cognition and Behavior ,F.01,F,F.01,
497,F.01.a. Perception and imagery,F.01.a,F,F.01,F.01.a
498,F.01.b. Human learning: Perceptual and spatial learning,F.01.b,F,F.01,F.01.b
499,F.01.c. Human learning: Motor and sequence learning,F.01.c,F,F.01,F.01.c
500,"F.01.d. Human learning: Feedback, reinforcement and reward ",F.01.d,F,F.01,F.01.d
501,F.01.e. Human long-term memory: Medial temporal lobe ,F.01.e,F,F.01,F.01.e
502,F.01.f. Human long-term memory: Retrieval,F.01.f,F,F.01,F.01.f
503,F.01.g. Human long-term memory: Encoding ,F.01.g,F,F.01,F.01.g
504,F.01.h. Human long-Term memory: Encoding-retrieval interactions ,F.01.h,F,F.01,F.01.h
505,F.01.i. Functional mechanisms of attention ,F.01.i,F,F.01,F.01.i
506,F.01.j. Attentional networks,F.01.j,F,F.01,F.01.j
507,F.01.k. Disorders of attention ,F.01.k,F,F.01,F.01.k
508,F.01.l. Executive function ,F.01.l,F,F.01,F.01.l
509,F.01.m. Language,F.01.m,F,F.01,F.01.m
510,F.01.n. Emotion,F.01.n,F,F.01,F.01.n
511,F.01.o. Working memory,F.01.o,F,F.01,F.01.o
512,F.01.p. Decision making and reasoning ,F.01.p,F,F.01,F.01.p
513,F.01.q. Cognitive development,F.01.q,F,F.01,F.01.q
514,F.01.r. Cognitive aging ,F.01.r,F,F.01,F.01.r
515,F.01.s. Individual differences,F.01.s,F,F.01,F.01.s
516,F.01.t. Timing and temporal processing,F.01.t,F,F.01,F.01.t
517,F.01.u. Social cognition: Behavior and pharmacology,F.01.u,F,F.01,F.01.u
518,F.01.v. Social cognition: Neural processes and disorders,F.01.v,F,F.01,F.01.v
519,F.02. Animal Cognition and Behavior ,F.02,F,F.02,
520,F.02.a. Functional mechanisms of attention ,F.02.a,F,F.02,F.02.a
521,F.02.b. Pharmacology of attention ,F.02.b,F,F.02,F.02.b
522,F.02.c. Appetitive and incentive learning and memory ,F.02.c,F,F.02,F.02.c
523,F.02.d. Executive function: Learning and memory ,F.02.d,F,F.02,F.02.d
524,F.02.e. Executive function: Network activity ,F.02.e,F,F.02,F.02.e
525,F.02.f. Executive function: Decision making ,F.02.f,F,F.02,F.02.f
526,F.02.g. Executive function: Models of Disorders ,F.02.g,F,F.02,F.02.g
527,F.02.h. Memory consolidation and reconsolidation: Behavior ,F.02.h,F,F.02,F.02.h
528,F.02.i. Memory consolidation and reconsolidation: Molecular mechanisms ,F.02.i,F,F.02,F.02.i
529,F.02.j. Memory consolidation and reconsolidation: Neural mechanisms ,F.02.j,F,F.02,F.02.j
530,F.02.k. Learning and memory: Cortical circuits ,F.02.k,F,F.02,F.02.k
531,F.02.l. Learning and memory: Hippocampal circuits ,F.02.l,F,F.02,F.02.l
532,F.02.m. Learning and memory: Gamma and theta activity ,F.02.m,F,F.02,F.02.m
533,"F.02.n. Learning and memory: Genes, signaling, and neurogenesis ",F.02.n,F,F.02,F.02.n
534,F.02.o. Learning and memory: Physiology ,F.02.o,F,F.02,F.02.o
535,F.02.p. Learning and memory: Pharmacology ,F.02.p,F,F.02,F.02.p
536,F.02.q. Learning and memory: Aging ,F.02.q,F,F.02,F.02.q
537,F.02.r. Learning and memory: Invertebrates ,F.02.r,F,F.02,F.02.r
538,F.02.s. Cortical and hippocampal circuits: Timing and temporal processing ,F.02.s,F,F.02,F.02.s
539,F.02.t. Cortical and hippocampal circuits: Spatial navigation ,F.02.t,F,F.02,F.02.t
540,F.02.u. Thalamic and brainstem circuits ,F.02.u,F,F.02,F.02.u
541,F.02.v. Prefrontal/striatal systems ,F.02.v,F,F.02,F.02.v
542,F.02.w. Temporal lobe systems ,F.02.w,F,F.02,F.02.w
543,"F.02.x. Associative, nonassociative, and skill learning ",F.02.x,F,F.02,F.02.x
544,F.02.y. Fear and aversive learning and memory: Acquisition ,F.02.y,F,F.02,F.02.y
545,F.02.z. Fear and aversive learning and memory: Modulation ,F.02.z,F,F.02,F.02.z
546,F.02.aa. Fear and aversive learning and memory: Development ,F.02.aa,F,F.02,F.02.aa
547,F.02.bb. Fear and aversive learning and memory: Extinction ,F.02.bb,F,F.02,F.02.bb
548,F.02.cc. Fear and aversive learning and memory: Amygdala and extended amygdala circuits ,F.02.cc,F,F.02,F.02.cc
549,F.02.dd. Fear and aversive learning and memory: Hippocampal related circuits,F.02.dd,F,F.02,F.02.dd
550,F.03. Motivation and Emotion ,F.03,F,F.03,
551,F.03.a. Reward: Dopamine ,F.03.a,F,F.03,F.03.a
552,F.03.b. Reward: Motivational mechanisms ,F.03.b,F,F.03,F.03.b
553,F.03.c. Reward: Neuropharmacology ,F.03.c,F,F.03,F.03.c
554,F.03.d. Decision making: Neurocircuitry,F.03.d,F,F.03,F.03.d
555,F.03.e. Decision making: Neuropharmacology,F.03.e,F,F.03,F.03.e
556,F.03.f. Motivation and emotions: Neurocircuitry ,F.03.f,F,F.03,F.03.f
557,"F.03.g. Motivation and emotions: Fear, anxiety, and pain",F.03.g,F,F.03,F.03.g
558,F.03.h. Motivation and emotions: Reward,F.03.h,F,F.03,F.03.h
559,F.03.i. Motivation and emotions: Negative emotional states ,F.03.i,F,F.03,F.03.i
560,F.03.j. Motivation and emotions: Risk taking ,F.03.j,F,F.03,F.03.j
561,F.03.k. Motivation and emotions: Social communication ,F.03.k,F,F.03,F.03.k
562,F.03.l. Motivation and emotions: Information processing,F.03.l,F,F.03,F.03.l
563,F.04. Neuroethology ,F.04,F,F.04,
564,F.04.a. Sensory and motor systems ,F.04.a,F,F.04,F.04.a
565,F.04.b. Vocal/social communication: Avian ,F.04.b,F,F.04,F.04.b
566,F.04.c. Vocal/social communication: Non-avian ,F.04.c,F,F.04,F.04.c
567,F.04.d. Seasonal and sex differences,F.04.d,F,F.04,F.04.d
568,Back to Top »,,,,
569,,,,,
570,G. Novel Methods and Technology Development,G,G,,
571,"G.01. Molecular, Biochemical, and Genetic Techniques  ",G.01,G,G.01,
572,G.01.a. Molecular/biochemical techniques ,G.01.a,G,G.01,G.01.a
573,G.01.b. Genetic techniques,G.01.b,G,G.01,G.01.b
574,"G.02. Genomics, Proteomics, and Systems Biology  ",G.02,G,G.02,
575,"G.02.a. Genomics, proteomics, and systems biology",G.02.a,G,G.02,G.02.a
576,"G.03. Staining, Tracing, and Imaging Techniques ",G.03,G,G.03,
577,"G.03.a. Staining, tracing, and imaging techniques: Light microscopy ",G.03.a,G,G.03,G.03.a
578,"G.03.b. Staining, tracing, and imaging techniques: Trans-synaptic tracing ",G.03.b,G,G.03,G.03.b
579,"G.03.c. Staining, tracing, and imaging techniques: Electron microscopy ",G.03.c,G,G.03,G.03.c
580,"G.03.d. Staining, tracing, and imaging techniques: Novel probes",G.03.d,G,G.03,G.03.d
581,G.04. Physiological Methods ,G.04,G,G.04,
582,G.04.a. Optical methods,G.04.a,G,G.04,G.04.a
583,G.04.b. Optogenetics ,G.04.b,G,G.04,G.04.b
584,G.04.c. Electrophysiology: Cellular,G.04.c,G,G.04,G.04.c
585,G.04.d. Electrophysiology: Neural networks,G.04.d,G,G.04,G.04.d
586,G.04.e. Electrophysiology: Electrode arrays,G.04.e,G,G.04,G.04.e
587,G.04.f. Electrophysiology: Stimulating neurons,G.04.f,G,G.04,G.04.f
588,G.04.g. Novel assays,G.04.g,G,G.04,G.04.g
589,G.05. Bioinformatics  ,G.05,G,G.05,
590,G.05.a. Bioinformatics,G.05.a,G,G.05,G.05.a
591,"G.06. Computation, Modeling, and Simulation ",G.06,G,G.06,
592,G.06.a. Cellular models,G.06.a,G,G.06,G.06.a
593,G.06.b. Network models: Theory,G.06.b,G,G.06,G.06.b
594,G.06.c. Network models: Experimentation,G.06.c,G,G.06,G.06.c
595,G.06.d. Computational tools,G.06.d,G,G.06,G.06.d
596,G.07. Data Analysis and Statistics ,G.07,G,G.07,
597,G.07.a. Data analysis and statistics: Human data ,G.07.a,G,G.07,G.07.a
598,G.07.b. Data analysis and statistics: Proteomics ,G.07.b,G,G.07,G.07.b
599,G.07.c. Data analysis and statistics: Neuronal networks ,G.07.c,G,G.07,G.07.c
600,G.07.d. Software tools,G.07.d,G,G.07,G.07.d
601,Back to Top »,,,,
602,,,,,
603,"H. History, Teaching, Public Awareness, and Societal Impacts in Neuroscience",H,H,,
604,H.01. History of Neuroscience  ,H.01,H,H.01,
605,H.01.a. History of neuroscience,H.01.a,H,H.01,H.01.a
606,H.02. Teaching of Neuroscience ,H.02,H,H.02,
607,H.02.a. K-12 ,H.02.a,H,H.02,H.02.a
608,H.02.b. College,H.02.b,H,H.02,H.02.b
609,H.02.c. Graduate and professional,H.02.c,H,H.02,H.02.c
610,H.03. Public Awareness of Neuroscience  ,H.03,H,H.03,
611,H.03.a. Outreach activities,H.03.a,H,H.03,H.03.a
612,H.04. Ethical and Policy Issues in Neuroscience ,H.04,H,H.04,
613,H.04.a. Ethical and policy issues in neuroscience,H.04.a,H,H.04,H.04.a
614,Back to Top »,,,,
615,,,,,
616,,,,,
